Other agents were obtained as follows: compound 48/80 (COM), Sigma Chemical; disodium cromoglycate (DSCG), Biomol Research Laboratories Inc.; diphenhydramine hydrochloride (DPH), Nacalai Tesque; platelet activating factor (PAF), Funakoshi Co., Ltd.; rac 3-(N-n-octadecylcarbamoyloxy)-2-methoxypropyl 2-thiazoliethyl phosphate (CV-3988) and hen egg-white lysozyme (HEL), Wako Pure Chemical Industries, Ltd.; serotonin hydrochloride (5-HT), Tokyo Kasei Kogyo Co., Ltd.; ketanserin tartrate (KS), Research Biochemicals Inc.; protease (PA), Worthington Biochemical Co; diazepam, Takeda Chemical Industries, Ltd. Each test sample or agent used for the present experiments was dissolved in 100 ml water per 10 g body weight in the case of oral administration (p.o.), and in 10 ml saline per 10 g body weight in the case of intravenous (i.v.), intraperitoneal (i.p.) and subcutaneous (s.c.) administration before use in the biological experiments.
HEL-Sensitization and Challenge Immunization with HEL was performed as previously described. 7, 10) Male ddY mice 5 weeks of age were sensitized i.p. with 50 mg of HEL on day 0. To provoke IgE-dependent anaphylaxis, on day 9 each HEL-sensitized mouse was challenged by i.v. injection into the tail vein with HEL 1 mg/saline 30 ml for BP monitoring 7) or HEL 10 mg/saline 30 ml for BF monitoring.
10)
Blood Pressure (BP) Measurement The BP of the mice was measured using a BP monitoring system as previously reported. 7, 9) The change in systolic BP of the tail artery of unanaesthetized mice was measured every 2 min for 20 min immediately after challenge with HEL or COM using a nondirect-type BP monitor (MK-1030, Muromachi Kikai, Japan). Each mouse was placed on a holder in a measuring chamber kept at 36°C throughout the pre-warming period for 15 min prior to the experiment. The normal BP (90-110 mmHg) of each mouse was measured 10 min before each experiment. The results were expressed as the percentage of normal BP at given times after this injection, because there were individual differences in the BP of normal mice. If the BP decreased below the range (30 mmHg) of the monitor level, we used the value equivalent to 30% of the normal BP. Blood Flow (BF) Measurement The BF of the mice was measured using a BF monitoring system as previously reported.
10) The change in BF of the tail venous microciruculation of unanaesthetized mouse was measured every 2 min for 20 min immediately after challenge using a noncontact type laser-doppler blood flow meter (FLO-N1, Neoursience). Each mouse was placed on a holder in a measuring chamber kept at 36°C throughout the pre-warming period for 15 min prior to the experiment. The normal BF of each HEL-sensitized mouse was measured for 10 min before challenge with HEL. The results were expressed as the percentage of normal BF at given times after challenge with HEL, because there were individual differences in the BF of normal mice. If a mouse died due to fatal shock after challenge during measurement, the BF was converted to 0%. Assay of Inhibitory Effects on Antigen-Induced Anaphylaxis The inhibitory effect on IgE-dependent anaphylaxis was investigated as previously reported using BP [7] [8] [9] or BF. 10) IT (200 mg/kg) and compounds 1-3 (20 mg/kg) were individually administered i.p. or p.o. 1 h before challenge with HEL. As a control, water-treated mice were challenged with HEL alone. None of IT and compounds 1-3 affected the BP or BF in i.p. or p.o. administration to HEL-sensitized mice without challenge (data not shown).
Measurement of Scratching Behavior
The scratching behavior of the mice was measured using a previously reported method.
11) The pruritogenic agent was injected s.c. into the base of the neck on the back of mice to provoke scratching behavior. The incidences of scratching behavior on the whole body were counted for 20 min. As a control, water-treated or saline-treated mice were injected with the pruritogenic agent alone to examine the incidence of scratching behavior. The normal group was administrated i.v. or p.o. with saline or water alone without injection of the pruritogenic agents. The results were expressed as the percentage of scratching behavior of the control group.
Assay of Inhibitory Effects on COM-Induced Scratching Behavior COM (3 mg/kg) was injected to provoke scratching behavior. IT (100 mg/kg p.o. or i.v.), compounds 2 (10 mg/kg p.o. or 10 mg/kg i.v.) and 3 (10 mg/kg p.o.) were individually administered 1 h before injection with COM. As a positive control, DSCG was administered i.v. at 10 mg/kg 1 h before injection with COM, and DPH was administered i.p. at 10 mg/kg 30 min before injection with COM.
Assay of Inhibitory Effects on PAF-, 5-HT-and PA-Induced Scratching Behavior PAF (10 mg/kg), 5-HT (10 mg/kg) and PA (1 mg/kg) were injected to provoke scratching behavior. IT was administered i.v. at 100 mg/kg 1 h before injection with PAF, 5-HT or PA. As a positive control, CV-3988 (10 mg/kg) and KS (2 mg/kg) were individually administered i.v. 30 min before injection with PAF or 5-HT.
Assay of Sedative Activity Using Locomotive Behavior Experiments
The locomotive behavior of mice was measured as previously reported. 12) IT (100 mg/kg) and saline (control group) were individually administered i.v. 1 h before the experiment. As a positive control, diazepam (5 mg/kg) was administered s.c. 30 min before measuring locomotion. Locomotive activity was evaluated as the frequency at which a mouse crossed a line during the 20 min observation period.
Statistical Analysis Statistical analysis was performed with analysis of variance with nested model design, followed Dunnett's multiple comparison test coupled with Bonferroni inequality, which is a special statistical approach used to reduce error risk. Probability (p) values less than 0.05 were considered to be statistically significant. Figure 1 shows the inhibitory effects of IT, the principal compounds of IT and DSCG on BP decrease induced by COM. IT (Fig. 1A) , compounds 1-3 (Fig. 1B) and DSCG, 13) a classical anti-degranulating agent, (Fig. 1C) all significantly inhibited BP decrease. We have observed that COM also causes BF decrease. This result will be reported in due course together with the application of this assay method.
RESULTS

Inhibitory Effects on COM-Induced BP Decrease
Inhibitory Effects on Antigen-Induced Anaphylaxis Since the principal compounds of IT significantly inhibited the IgE-independent anaphylaxis-like response, we further examined the inhibitory effects of these compounds on antigen-induced anaphylaxis. Figure 2 shows of inhibitory effects of compounds 1-3 on BP decrease induced by antigen-induced anaphylaxis. These compounds all significantly inhibited BP decrease. Figure 3 shows the inhibitory effects of IT and the principal compounds of IT on BF decrease induced by antigen-induced anaphylaxis. IT significantly inhibited BF decrease (Fig. 3A) , but compounds 1-3 did not (Fig. 3B) . The results were different for the anti-anaphylactic active compounds in the BP and BF monitoring assays.
Inhibitory Effects on COM-Induced Scratching Behavior The incidence of scratching behavior of the control group for 20 min is 599.9Ϯ64.5 counts. Figure 4 shows the inhibitory effects of IT, the principal compounds of IT and the inhibitory agents on COM-induced scratching behavior. Incidence of scratching is shown as a percentage of the control. IT in i.v. administeration significantly inhibited COMinduced scratching behavior. But IT in p.o. administration did not inhibit the scratching behavior. We examined the inhibitory effect of compound 2 in i.v. administration at 10 mg/kg (the maximum dose considering the solubility in saline). Compound 2 did not show the inhibitory effect (data not shown). Compounds 1 and 3 could not be injected i.v., because they could not be dissolved in saline. We also examined the inhibitory effects of 2 and 3 in p.o. administration at dose of 10 mg/kg, because the anti-pruritic effect of 1 in p.o. administration was previously reported.
12) The results showed that 2 and 3 decreased COM-induced scratching behavior, but not significantly.
Inhibitory Effects on PAF-, 5-HT-and PA-Induced Scratching Behavior The incidence of scratching behavior of each control group for 20 min is as follows: PAF; 431.2Ϯ99.8 counts, 5-HT; 410.6Ϯ93.1 counts, PA; 472.7Ϯ 157.7 counts. As a normal, the mice were injected i.v. with saline alone. The incidence of scratching behavior of normal group for 20 min is 93.6Ϯ9.0 counts. Table 1 shows the inhibitory effects of IT, apigenin (1) and the inhibitory agent against PAF-, 5-HT-and PA-induced scratching behavior. Incidence of scratching is shown as a percentage of the control. IT significantly inhibited PAF-and 5-HT-induced scratching behavior. IT decreased PA-induced scratching behavior, but not significantly. Compound 1 in p.o. administration showed inhibitory effects on PAF-and 5-HT-induced scratching behavior.
12)
Inhibitory Effects against Locomotive Behavior The locomotive activity of the control group for 20 min was 108.2Ϯ27.2 counts. IT did not inhibit the locomotive behavior of mice. However, diazepam, the positive control, suppressed it (data not shown). This suggested that the sedative action of IT did not involve in the inhibitory mechanism of scratching behavior.
DISSCUSION
IT significantly inhibited COM-induced BP decrease, which is an IgE-independent anaphylaxis-like response (Fig.  1A) . The principal compounds 1-3 from IT showed the inhibitory effect on COM-induced BP decrease (Fig. 1B) . Furthermore, these compounds significantly inhibited BP decrease induced by antigen-induced anaphylaxis (Fig. 2) as well as previously reported [7] [8] [9] positive controls, DSCG, DPH, 14) and CV-3988, 15 ) the anti-allergic drug currently used. It has been reported that the main flavones from IT, apigenin (1) and luteolin (3) have the inhibitory effects of degranulation, 17) histamine release, 18, 19) and production of Th2-type cytokine (interleukin-4, 5 and 13), 20) which plays a role in the enhancement of anaphylaxis 21) and synthesis of the secondary mediators of anaphylaxis, such as prostaglandins and leukotrienes and PAF, started by the degranulating reaction in vitro. 22, 23) Those compounds also showed a PAF-antagonistic effect in vivo as previously reported. 5) Thus, 1 and 3 were suggested to inhibit anaphylaxis-induced BP decrease by several mechanisms as noted in these reports or findings. Apigenin 7-glucoside (2) has anti-inflammatory activity due to its antioxidant effects in vivo, 24) however, there has been no report on the inhibitory effects of compound 2 against anaphylaxis. In the present experiment, the anti-anaphylactic effects of compound 2 were clarified for the first time.
IT significantly inhibited BF decrease induced by antigeninduced anaphylaxis (Fig. 3A) , but compounds 1-3 did not show the inhibitory effects of the BF decrease induced by the anaphylaxis (Fig. 3B) . As a positive control, DSCG, CV-3988 and KS 16) of a 5-HT 2A antagonistic agent, all showed significant inhibitory effects on BF decrease induced by IgEdependent anaphylaxis.
10) The mechanism of BP and BF decrease on challenge with HEL has not been completely clarified. We have previously reported that histamine 8) and PAF 9) acted as initiators of the BP decrease induced by IgE-dependent anaphylaxis, whereas 5-HT sustained the anaphylaxis.
In the case of the BF decrease induced by the anaphylaxis, 5-HT acted as an initiator, but histamine did not affect it at all. 10) On the other hand, PAF was not an initiator, but acted as an important factor in the BF decrease. 10) In a related study, we have observed that the BF of the mouse tends to decrease in response to HEL-sensitization (the stage preceding anaphylaxis) without any change in BP. 25) In any case, the present results support a difference in the mechanisms between the BP decrease and the BF decrease induced by anaphylaxis, and are extremely interesting. Further work is needed to search for the principal active compounds that can inhibit anaphylaxis-induced BF decrease and to elucidate the details of the mechanisms involved.
IT in i.v. administration significantly inhibited the scratching behavior (itch-associated response) induced by COM, but the extract in p.o. administration did not (Fig. 4) . This result suggested that the active compounds may differ among BF decrease, BP decrease and pruritus. More detailed examination including of pharmacokinetical data is necessary.
The anti-pruritic effect of IT dose not seem to be dependent on the central nervous system, because it did not inhibit the locomotive activity of the mice. Instead, it seems to be dependent on the inhibitory effects against PAF and 5-HT, pruritic factors similar to histamine 26) (Table 1 ). In addition, IT decreased the scratching behavior induced by PA, which specifically increases in inflammation or allergy lesion 27) ( Table 1) . IT offers promise as a drug for the treatment of allergic and inflammatory pruritus. Further work is needed on the antagonistic effects of IT on PAF and 5-HT 2A receptors.
Compound 1 could not be injected i.v., because it was not soluble in saline. However, in case of the i.v. administration of IT, compound 1 might contribute in the activity by the solubilizing effect of coexisting compound. In p.o. administration, compound 1 showed the inhibitory effects on COM, PAF and 5-HT-induced scratching behavior (Fig. 4, Table 1 ), without a central depressant action.
12) Kaempferol 3-rhamnosyldiglucoside, which was previously isolated from IT, has a significant anti-pruritic effect in i.v. administration. 28) Other The mice were injected s.c. with COM-, PAF, 5-HT or PA without pretreatment (control) or following pretreatment i.v. with IT, CV-3988 and KS. All values are meanϮS.E.M. for 5 mice. * pϽ0.05, * * pϽ0.01 (compared with control). Data of compound 1 cited from previous report. 12) active compounds are also being subjected to further study.
To our knowledge, this is the first report of the inhibitory effects of IT against the anaphylaxis and the scratching behavior induced by several pruritogenic agents. Thus, the flowers of I. textori should be useful as an anti-anaphylactic and anti-pruritic material in addition to the traditional applications of this plant.
